Moreover, further research by protein-protein interaction network analysis showed that SMC4 was closely associated with MELK and TTK, which were promising candidate markers for cervical cancer prognosis and also emerged as potential therapeutic drug targets (37). Here, SMC4 is linked to cervical carcinoma.